Phase II Study of Pazopanib and Topotecan in Cervical Cancer

NCT02348398 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Pazopanib
DRUG: Topotecan
BEHAVIORAL: Phone Call

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]